Kauffman Chiropractic - Medicare Chiropractor in Crown Point, IN

Kauffman Chiropractic is a medicare enrolled "Chiropractor" provider in Crown Point, Indiana. Their current practice location is 7620 E. 109th Ave., Crown Point, Indiana. You can reach out to their office (for appointments etc.) via phone at (219) 662-9855.

Kauffman Chiropractic is licensed to practice in Indiana (license number 08001232) and it also participates in the medicare program. Kauffman Chiropractic is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1114149366.

Contact Information

Kauffman Chiropractic
7620 E. 109th Ave.,
Crown Point, IN 46307
(219) 662-9855
(219) 662-1290



Healthcare Provider's Profile

Full NameKauffman Chiropractic
TypeFacility
SpecialityChiropractor
Location7620 E. 109th Ave., Crown Point, Indiana
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1114149366
  • Provider Enumeration Date: 05/03/2007
  • Last Update Date: 01/30/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 1951440569
  • Enrollment ID: O20091120000024

Medical Identifiers

Medical identifiers for Kauffman Chiropractic such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1114149366NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
111N00000XChiropractor 08001232 (Indiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Kauffman Chiropractic acts as a billing entity for following providers:
Provider NameRobert H Kauffman
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1366459158
PECOS PAC ID: 5294874806
Enrollment ID: I20111205000020

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameDanielle B Kauffman
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1265449375
PECOS PAC ID: 2668511270
Enrollment ID: I20111208000002

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameKelsi J Dimitt
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1770909624
PECOS PAC ID: 7810120581
Enrollment ID: I20140502001559

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameNicholas P Kauffman
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1245614650
PECOS PAC ID: 0840506093
Enrollment ID: I20150902001330

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameKristina A Kauffman
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1992169114
PECOS PAC ID: 4486944949
Enrollment ID: I20160613000838

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameJohn P Mcdonald
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1013462373
PECOS PAC ID: 1254627979
Enrollment ID: I20170517000302

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameTyler Michael Gress
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1154893717
PECOS PAC ID: 7810235645
Enrollment ID: I20190220001939

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameMichael Kauffman
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1225507205
PECOS PAC ID: 9335489624
Enrollment ID: I20190325000496

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameTracey L Curtis
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1346842978
PECOS PAC ID: 5092106013
Enrollment ID: I20211231000058

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Provider NameMallory A Lehman
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1285369413
PECOS PAC ID: 0840672150
Enrollment ID: I20220803002184

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kauffman Chiropractic is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kauffman Chiropractic
7620 E. 109th Ave.,
Crown Point, IN 46307

Ph: (219) 662-9855
Kauffman Chiropractic
7620 E. 109th Ave.,
Crown Point, IN 46307

Ph: (219) 662-9855

News Archive

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos Therapeutics, Inc. and Mundipharma International Corporation Limited today jointly announced that the companies have entered into a strategic collaboration agreement to co-develop FOLOTYN (pralatrexate injection).

Largazole appears to be an ideal blueprint for developing new drugs against bone diseases

One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.

Read more News

› Verified 8 days ago


Chiropractor in Crown Point, IN

Dr. Darcy Danielle Crowder, D.C.
Chiropractor
Medicare: Accepting Medicare Assignments
Practice Location: 7620 E 109th Ave, Crown Point, IN 46307
Phone: 219-662-9855    Fax: 219-662-1290
Dr. Steven G Kouimanis, D.C.
Chiropractor
Medicare: Not Enrolled in Medicare
Practice Location: 11039 Broadway, Suite C, Crown Point, IN 46307
Phone: 219-662-9090    Fax: 219-662-9191
J.s. Jordan Professional Services Corp
Chiropractor
Medicare: Not Enrolled in Medicare
Practice Location: 300 N Main St Ste C, Crown Point, IN 46307
Phone: 219-662-7711    Fax: 219-662-7740
Dr. Douglas Ryan Evenhouse, D.C.
Chiropractor
Medicare: Accepting Medicare Assignments
Practice Location: 566 N Indiana Ave, Crown Point, IN 46307
Phone: 219-213-2315    
Lifestyle Chiropractic & Progressive Rehab
Chiropractor
Medicare: Not Enrolled in Medicare
Practice Location: 11065 Broadway, Bldg 12 Ste A, Crown Point, IN 46307
Phone: 312-909-1518    
Back & Joint Rehab Center
Chiropractor
Medicare: Medicare Enrolled
Practice Location: 127 E 113th Ave, Crown Point, IN 46307
Phone: 219-331-6041    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.